Match Document Document Title
8183228 Anticoagulant antithrombotic dual inhibitors comprising a biotin label  
The present invention relates compounds of the formula: oligosaccharide-spacer-(GpIIb/IIIa antagonist), wherein the oligosaccharide is a negatively charged oligosaccharide residue comprising four...
8173798 Vaccine  
The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine including one or more immunogenic components for Neisseria serogroups, as well as antibodies to the...
8168767 Formulations and methods for solid chitosan-containing blends  
Chitosan-containing blends and methods of dissolving and using chitosan are disclosed. A blend includes a solid acid or a solid agent that generates a proton in situ in the presence of water mixed...
8168778 Highly-branched starch, its production and uses  
An object of the present invention is to provide a novel starchy substance having a retrogradation-resistance, a process for producing the starchy substance efficiently from a material starch by...
8163715 Inulin of very high chain length  
The invention relates to a long-chain inulin and its preparation from artichoke roots, to its use in foodstuffs and cosmetic preparations and to foodstuffs and cosmetic preparations which comprise...
8158608 Bioactive fraction from Zingier officinale and a process for the preparation thereof  
Ulcer is a serious oxidative stress induced disease with complex pathologic events including upregulation of H+K+ ATPase of parietal cell (PC) membrane, damage of mucin layer around PC, PC-DNA...
8143235 Use of dietary fibres against muscle wasting  
A composition nutritional containing dietary fibres is useful for the treatment of muscle wasting, if the dietary fibre comprise at least 30 wt. % of galacto-oligosaccharides or other...
8137681 Polyanionic polymer adjuvants for Haemophilus influenzae B saccharide vaccines  
The present invention relates to the field of vaccines, and in particular vaccines comprising antigens of low isoelectric point at pH 7.0, in particular the capsular polysaccharide or...
8137685 Hyaluronic acid compound, hydrogel thereof and joint treating material  
A hyaluronic acid compound which is a reaction product between hyaluronic acid and a phosphatidyl ethanolamine. This compound has biocompatibility and bio-safety, and can be formed into a hydrogel...
8129128 Immunoassay reagent compositions for diagnosing multiple sclerosis  
This application is related to immunoassay reagent compositions comprising a glycan reagent for diagnosing multiple sclerosis.
8124575 Polymeric surfactants based upon alkyl polyglycosides and sugars  
The present invention relates to a series of polyglycoside derivatives that are (a) polymeric (that is cross linked with hydroxypropyl linkages) and (b) contain additional functional groups...
8114466 Methods of applying coating to the inside surface of a stent  
A method of applying a coating material to a stent includes the steps of providing a generally tubular stent having an inside surface and an outside surface and applying a coating material to the...
8114856 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents  
The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection.
8110677 Microwave-assisted extraction of polysaccharide from Artemisia sphaerocephala  
This invention relates to a method of extracting crude polysaccharide by microwave-assisted from Artemisia sphaerocephala seed de-oiling dregs. In particular, the invention comprising:...
8110380 Starch-based biodegradable material composition  
A starch-based biodegradable material composition includes: an enzyme-hydrolyzed starch; and a biodegradable polyester selected from at least one of an aliphatic polyester of polybutylene succinate...
8106007 Conjugates of a polypeptide and a pentasaccharide  
The present invention relates to conjugates of a polypeptide and an oligosaccharide, wherein the polypeptide is conjugated to at least one oligosaccharide-spacer residue, the oligosaccharide being...
8097437 Highly pure polysialic acid and process for preparation thereof  
The instant invention provides highly pure Polysialic acid and process for preparation thereof.
8088626 Chiral selectors for separating enantiomers of a compound  
The invention relates to the use of compounds as new chiral selectors for separating the optical or enantiomeric isomers of a compound, wherein the chiral selector comprises at least one compound...
8084053 Dry mouldable drug formulation  
Solid pharmaceutical compositions and methods of making and administering for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the...
8076313 Composition containing fermentable polysaccharides  
The present invention relates to a composition to a nutritional composition comprising 0.1 to 15 gram fermentable e partially hydrolysed gum having a degree of polymerization between 10 and 300 per...
8071758 Method for production of limulus-positive glycolipid, the limulus-positive glycolipid, and composition containing the limulus-positive glycolipid  
It has been found that a limulus-positive glycolipid is present in xanthan gum derived from Xanthomonas, which has been commercially available and eaten for many years, and this was purified, and...
8071759 Water soluble cholesterol derivatives  
Four novel water soluble cholesterol derivative compounds are disclosed. These compounds have various applications in studies of membrane proteins, including drug screening and studies of receptor...
8071569 Oxidized heparin fractions and their use in inhibiting angiogenesis  
The present invention relates to a heparin fraction comprising constituents having molecular weights of from about 2,000 to about 4,000 daltons, wherein from about 1% to about 100% of hydroxyl...
8053543 Filler for optical isomer separation  
A polymer compound derivative, obtained by modifying part of the hydroxy or amino groups of a polymer compound having the hydroxy or amino groups with molecules of a compound represented by the...
8048997 Process for drying uronic acid oligosaccharides  
The present invention relates to a process for spray drying uronic acid oligosaccharides and to a powder compositions thus obtained. Typically the powder composition comprises between 25 and 100...
8049004 Processes for making ethersuccinylated hydroxyl polymers  
Processes for making ethersuccinylated hydroxyl polymers are provided.
8026221 Method, composition and kit for antigenic binding of norwalk-like viruses  
A method for detecting a Norwalk-Like Virus (NLV) in a biological sample, comprising the steps of: obtaining a biological sample suspected of containing a NLV; contacting the biological sample with...
8022049 Polysaccharide produced by microorganism belonging to genus Bifidobacterium  
A polysaccharide comprising galactose, glucose, rhamnose, and pyruvic acid as constituents, wherein the galactose, glucose, and rhamnose are contained in a molar ratio of 4:2:1, and the pyruvic...
8017133 Multicomponent vaccines  
Multicomponent vaccines are provided which aid in the prevention and treatment of staphylococcal infections and which include certain selected combinations of bacterial binding proteins or...
8013132 Synthetic compounds useful as nodulation agents of leguminous plants and preparation processes thereof  
The present invention relates to synthetic compounds that are active on plants, especially as legume nodulation factors, and also as plant growth stimulators, and to methods for preparing such...
8008275 Fucose containing proteoglycan or acidic glycan and their pharmaceutical use  
A class of proteoglycans containing fucosylated acidic glycans, e.g., as produced by marine sponges and sea urchin embryos, have been found to stimulate selective proliferation of mammalian natural...
8007818 Polyanionic polymer adjuvants for haemophilus influenzae B saccharide vaccines  
The present invention relates to the field of vaccines, and in particular vaccines comprising antigens of low isoelectric point at pH 7.0, in particular the capsular polysaccharide or...
8008276 Use of zwitterionic polysaccharides for the specific modulation of immune processes  
The invention relates to three-dimensional molecular structure determination of polymers, three-dimensional computer molecular modeling, rational drug design, and immunomodulatory polymers. In...
8003112 Meningococcal and pneumococcal conjugate vaccine and method of using same  
This disclosure relates to vaccine formulations comprising an immunogenic composition for inducing antibodies to both S. pneumoniae and N. meningitides in a subject. In a preferred aspect, the...
7989601 Heterobifunctional pan-selectin inhibitors  
Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the...
7964561 Protein formulations for use at elevated temperatures  
Liquid formulations of bone morphogenetic proteins are provided for prolonged use at elevated temperatures. More specifically, the invention relates to liquid formulations comprising rhGDF-5,...
7956046 Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them  
Oligosaccharide mixtures comprising anti-Xa activities of from 190 IU/mg to 450 IU/mg and anti-IIa activities of less than 0.2 IU/mg; and having constituent oligosaccharides with an average...
7956045 Compositions and methods for animal treatment  
A method of improving the health and production of ruminant animals, the method including the step of orally administering to the animal an effective amount of an indigestible oligosaccharide...
7956047 Use of chondroitin sulphate E (CS-E) for the treatment of diseases or conditions related to collagen fibril formation  
The present invention comprises the use of chondroitin sulphate (CS-E) or an active fragment thereof for the treatment of diseases or conditions related to collagen fibril formation. Said compounds...
7951530 Cyclic maltosylmaltose, cyclic maltosymaltose-forming enzyme, their preparation and uses  
An object of the present invention is to provide an option of non-reducing saccharide by providing a novel non-reducing saccharide composed of glucose as constituents and to provide a novel enzyme...
7943596 Medicinal composition for ophthal use containing acetylated hyaluronic acid  
The present invention provides an ophthalmic pharmaceutical composition containing acetylated hyaluronic acid and a pharmacologically acceptable carrier. Preferably, the average molecular weight of...
7935683 Polysaccharide-carbon nanotube complex  
Disclosed is a complex which comprises a carbon nanotube and a modified polysaccharide having a backbone chain with the side thereof being introduced with monosaccharide or oligosaccharide...
7932236 Glycolipids  
Novel synthetic gangliosides and pharmaceutical compositions containing such synthetic gangliosides are described. Methods of making the novel synthetic ganglioside compounds and compositions as...
7928079 Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates  
The invention relates to compounds capable of releasing nitric oxide wherein the compounds comprise a saccharide and at least one nitric oxide-releasing diazeniumdiolate [N2O2] functional group,...
7923018 Vaccine  
The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine comprising one or more immunogenic components for Neisseria serogroups, as well as antibodies to the...
7910117 Vaccine  
The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine including one or more immunogenic components for Neisseria serogroups, as well as antibodies to the...
7902172 Method of promoting bone growth with hyaluronic acid and growth factors  
A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site...
7902170 Influenza virus binding, sialylated oligosaccharide substance and use thereof  
The present invention is directed to human influenza virus binding substance containing at least one oligosaccharide chain, which comprises a terminal NeuNAcα6 linked to: (a) a linear or branched ...
7897563 Use of oligomers and polymers for drug solubilization, stabilization, and delivery  
The invention relates to the use of oligomers and polymers capable of rendering insoluble drugs soluble, protecting unstable drugs, and facilitating the delivery of drugs to their site of action....
7893039 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents  
The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection.